Codexis announced Q3 2026 revenue of $19.3 million, more than doubling from the prior year, driven by new product launches with higher margins. The company strengthened its balance sheet with a $25 million equity raise and a $60 million loan facility, refinancing existing debt. Codexis showcased progress in its ECO Synthesis Manufacturing Platform for RNA therapeutics, including successful scale-up and improved process efficiency. Looking ahead, Codexis plans to advance clinical manufacturing partnerships and complete its GMP production facility by the end of 2027, supporting siRNA clinical trials.
Codexis' Q3 2026 financial results and business update provide context for readers interested in health sector trends. For readers following health stocks, here is Pluang's market snapshot as of Nov 13, 2026 04:11 WIB: out of 150 priced health-sector US stocks tradable on Pluang, 23 rose and 124 fell today. Notable movers include BNGO at USD 1.00 with a 1-day change of -9.09% and a typical hold time of 52 days, FLNA at USD 0.44 down 8.71% with a 39-day hold time and a Pluang order activity of 87% Buy, and RLAY at USD 18.16 down 7.91% with a 34-day hold time.
Siemens reported earnings per share of $1.62 and revenue of $26.28 billion, both exceeding analyst expectations. The company saw record orders and double-digit revenue growth in its smart infrastructure and digital industries units, prompting it to r...
ASUS has introduced a broad ecosystem of AI-ready hardware and software designed for gamers, creators, developers, and enterprises. The ASUS Agent Computer initiative enables users to deploy AI locally, in the cloud, or via hybrid models, offering co...
The global cosmetic peptide synthesis market is projected to grow from $274 million in 2027 to $354.85 million by 2032, with a CAGR of 5.34%. Growth is fueled by rising demand for advanced anti-aging skincare ingredients, increased use of peptide-bas...
Cisco is set to report its fiscal Q1 2027 earnings with a focus on cloud growth and AI demand. Analysts expect revenue around $18.1 billion, operating income of $6.5 billion, and earnings per share of $1.33, reflecting strong year-over-year growth. T...
BASF has agreed to sell its global mining solutions business to SNF, a specialty chemical company based in France, following a strategic review of BASF's Performance Chemicals division. The deal includes BASF's mining chemicals portfolio, production ...
